Ann: Race Strategic Update March 2021, page-343

happy Easter to you too. Personally I was taken aback by your lack of respect to a fellow Race shareholder. Might I point out that in a post following this one I abandoned the idea of going to the mainstream media- I’ll leave that up to Races management to decide if and when they engage with the media. I don’t disagree with your comments about the real market being in America, and the importance of keeping under the radar from big Pahrmas attention until the appropriate time. I too have no intention of selling until there is a very large offer from big pharma, in my view that should be north of $100. The point I was trying to make in my first post on this was to engage the attention of the small domestic investor, with the aim o f giving the share price a boost. but as I said I’ve subsequently retraced from that view. Notwithstanding that, If you are advocating complete ‘radio silence’ for the next 12 months I think that is unrealistic because the company will either approach, or continue to be approached by investment commentators, or they will continue to post articles about the company.